FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jan. 31, 2012-- MEDNAX, Inc., (NYSE:MD) today announced that it is scheduled to make a presentation on Tuesday, February 7, 2012, at 3:30 p.m. EST, to investors attending the UBS 22nd Annual Healthcare Services Conference in New York, N.Y.
The presentation by MEDNAX's Chief Executive Officer, Roger J. Medel, M.D., will be broadcast through a live audio Webcast and will be available for replay at www.mednax.com/investors.
MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 300 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 900 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,800 physicians in 34 states and Puerto Rico. Additional information is available at http://www.mednax.com.
Source: MEDNAX, Inc.
David Parker, 954-384-0175, Ext. 5300
Vice President, Corporate Communications & Investor Relations